Roche Holding AG (SWX:ROG)
272.00
-0.40 (-0.15%)
May 5, 2025, 5:35 PM CET
Roche Holding AG Revenue
In the year 2024, Roche Holding AG had annual revenue of 62.40B CHF with 3.23% growth. Roche Holding AG had revenue of 31.64B in the half year ending December 31, 2024, a decrease of -0.86%.
Revenue
62.40B
Revenue Growth
+3.23%
P/S Ratio
3.51
Revenue / Employee
604.32K
Employees
103,249
Market Cap
218.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novartis AG | 47.05B |
Lonza Group AG | 6.57B |
Alcon | 8.98B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.41B |
Sonova Holding AG | 3.71B |
Ypsomed Holding AG | 617.07M |
Roche Holding AG News
- 2 days ago - Hanover Insurance CEO on tariffs: Situation is manageable due to cost visibility - CNBC
- 3 days ago - Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit - CNBC
- 4 days ago - Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development - Benzinga
- 4 days ago - Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom - CNBC
- 5 days ago - Blood-Based Biomarkers (BBB) Market Review 2023-2024 and Growth Opportunities 2025-2035 Featuring Profiles of Key Players - Roche, Sysmex Corporation, MiRXES, Minomic, Creative Diagnostics and More - GlobeNewsWire
- 5 days ago - CHMP recommends EU label update for Roche's Phesgo to allow administration outside of clinical settings - GlobeNewsWire
- 7 days ago - 'Roche could've earned over 100 times what it cost for rare disease drug' - The Times of India
- 7 days ago - Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus - Seeking Alpha